Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Correction: ICA Gruppen year-end report 2022

The correction refers to the name of the partner company in new jointly owned company. The corrected press release follows in its entirety.   A turbulent 2022 – strong customer focus ahead of 2023· The operating margin for ICA Gruppen fell in Q4 2022 to 3.9% (4.0%). · Operating profit for the fourth quarter of 2022 increased by 6.4%, driven by high inflation, to SEK 1,382 million compared with the fourth quarter of 2021 (1,298). · Q4 sales increased by 8.2% to SEK 35,547 million (32,860), also driven by inflation. · Drop in volume put pressure on earnings for ICA Gruppen’s

BioStock: Spago Nanomedical reports advancement

Lund-based Spago Nanomedical recently published its financial statements for 2022, where the company reports advancement within its projects with the upcoming start of clinical studies in Tumorad and the initiation of the company's first clinical phase II study with SpagoPix. BioStock reached out to CEO Mats Hansen to hear more about the company's ambitions for 2023.Read the interview with Spago Nanomedical's CEO Mats Hansen at biostock.se: https://www.biostock.se/en/2023/02/spago-nanomedical-reports-advancement/ This is a press release from BioStock - Connecting Innovation & Capital.

Correction: DBP International AB: investee company Bio Vitos has yesterday reached agreement with Hemcheck

The correction refers to the letter in the press release on February 8 at 07:48 CEST: The MAR label was put there by mistake and the agreement between Bio Vitos and Hemcheck was signed yesterday.   Double Bond Pharmaceutical International AB (publ) ("DBP") notes the announcement released earlier yesterday by Hemcheck Sweden AB (“Hemcheck”) and is pleased to announce that its 20% owned investee company Bio Vitos has today entered into an agreement with Hemcheck, a company listed on the Nasdaq Stockholm (the “Agreement”).  As part of the Agreement Hemcheck will create a new subsidiary (“

Wärtsilä and Carnival Corporation partner in sustainability pilot project to reduce plastic waste

Wärtsilä Corporation, Trade press release, 8 February 2023 at 10.00 AM EETThe technology group Wärtsilä and Carnival Corporation have carried out a joint pilot project to reduce plastic materials being used in marine operations. The aim of the project is to boost maritime sustainability by preventing plastics from harming the environment, and since plastics are formed from fossil fuels, to also lower CO2 emissions. As a result of this pilot, Wärtsilä Global Logistics Services is in the process of changing its spare part packaging to achieve a reduction of approximately 40 percent in the

Notice of Extraordinary General Meeting in CTEK AB (publ)

CTEK AB (publ), Reg. No. 559217-4659, with its registered office in Hedemora, Sweden gives notice of the Extraordinary General Meeting to be held on 3 March 2023 at 10:00 a.m. CET at Smålandsgatan 20 in Stockholm, Sweden. Registration starts at 09:30 a.m. CET. Right to participate in the Extraordinary General Meeting and notice of participation Participation in the Extraordinary General Meeting at the venue A shareholder who wishes to participate in the General Meeting at the venue in person or represented by a proxy must (i) be recorded as a shareholder in the share register

Hexagon Composites ASA: Invitation to fourth quarter and full-year 2022 results

08 February 2023: Hexagon Composites ASA's fourth quarter and full-year 2022 results will be released on 16 February 2023 at 07:00 am CET. Jon Erik Engeset, CEO and David Bandele, CFO will present the results at 08:30 am the same morning. The presentation will be held in the Auditorium at Hexagon's location in Oslo, Haakon VIIs gate 2, on the lower level. If you would like to attend the presentation, please pre-register by emailing ir@hexagongroup.com, alternatively register upon arrival.The presentation will also be broadcasted live via: https://channel.royalcast.com/hegnarmedia/#!/

Akobo Minerals wins prestigious ESG Nature award at Mining Indaba

OSLO, 08 February 2023: Akobo Minerals (Euronext Oslo – “AKOBO”), the Scandinavian-based Ethiopian gold exploration and boutique mining company, today announces that it has won the prestigious 2023 ESG Nature award at Mining Indaba, Cape Town.   Mining Indaba is Africa's premier mining expo, and one of the largest mining events in the world. With over 15,000 attendees we are delighted to have been recognized on such a prestigious occasion   Jørgen Evjen, CEO of Akobo Minerals, said: “We are proud to have been recognized for our ESG efforts by winning this prestigious award for

Covid-19 products face tougher future

We are in the midst of 2023’s first reporting period and many of the world’s largest pharmaceutical companies have presented their figures for the full year 2022. A theme is that products related to the Covid-19 pandemic seem to have reached their peak sales and will face a significantly tougher market going forward. BioStock took a closer look at some of the reports.Read the full article at biostock.se : https://www.biostock.se/en/2023/02/covid-19-products-face-tougher-future/ This is a press release from BioStock - Connecting Innovation & Capital. https:/

Betolar Plc: Financial Statements Release for 2022 will be published on 14 February – Invitation to Online Briefing

Betolar PlcPress Release, 8 February 2023 at 9:45 A.M. EET Betolar Plc: Financial Statements Release for 2022 will be published on 14 February – Invitation to Online Briefing Betolar Plc will publish its Financial Statements Release for January-December 2022 on Tuesday 14 February 2023, approximately at 8:30 Finnish time. An online briefing for investors, analysts and media will be arranged on the same day at 10 A.M. EET. The live webcast will be held in English and questions can be presented in written form in the webcast portal. The webcast will be hosted by CEO Riku Kytömäki

Gaming Innovation Group: Invitation to Q4 2022 results presentation

Gaming Innovation Group Inc. (GiG) publishes its interim report for the fourth quarter 2022 before market opening on Wednesday 15 February 2023. CEO Richard Brown will present the Q4 2022 results via livestream at 10:00 CET. The presentation will be followed by a Q&A-session, and investors, analysts and journalists are welcome to participate. The presentation will be given in English. Link to the livestream:https://www.redeye.se/events/869341/live-q-gaming-innovation-group-6 For further information, please contact:Tore Formo, Group CFO, tore@gig.com, +47 91668678  About

EdmoLift ranks among the top 8% in sustainability according to EcoVadis

For the ninth year in a row, EdmoLift has been awarded a gold medal for its exceptional sustainability efforts. EdmoLift is thus ranked among the top 8% of over 100,000+ global companies' CSR (Corporate Social Responsibility).Quality and environment have always been highly prioritised at EdmoLift. An area worked with for a long time. In later years, focus has been directed at energy consumption, environment, and working environment, but also the ethical part included in the analysis work. - Receiving a gold medal for our sustainability efforts is very joyful. It is proof that we work

Successful conclusion of EU project Alzheimer’s Detect & Prevent with early validation of two Brain+ DTx technologies and extra funding

Company Announcement Copenhagen, Denmark, February 8, 2023 – Brain+ A/S (Nasdaq First North: BRAINP) The information communicated in this announcement is “inside information” for the purposes of article 7 of the Market Abuse Regulation 596/2014 · The ‘Alzheimer’s Detect & Prevent’ project, led by Brain+ and funded under the EU Horizon2020 innovation framework, has been approved by the European Commission · The project has funded the development and early clinical feasibility testing of two key Brain+ technologies: 1) the ‘Starry Night’ cognitive test and 2) 1[st] generation

HC Andersen Capital Events 08/02: Meet the top management in Zerion Pharma & Inderes

HC Andersen Capital is hosting digital events where you can meet and ask questions directly to the top management. It is free for all to attend.Zerion Pharma - Company IntroductionMeet Zerion Pharma’s management team – CEO Ole Wiborg and CFO Jakob Dynnes Hansen when they introduce the company in relation to a private placement of 2-3 mio. EUR. Zerion Pharma is a non-listed Danish company.   The company aims to make a real difference in health care with its Dispersome™ technology in relation to the formulation of new and existing drugs. Poor drug solubility is one of the main reasons

TF Bank: Monthly statistics January 2023

The total loan portfolio amounted to SEK 14,793 million at the end of January. Compared to January 2022, the loan portfolio has increased by 27 % in local currencies.  Month Jan-23 Jan-22 ChangeConsumer Lending   New lending, SEK million 488 411 19 %Credit Cards   New lending, SEK million 592 256 131 %Ecommerce Solutions   Transaction volume*, SEK million 968 588 65 % *The sum of all purchases that go through TF Bank’s payment solutions All figures for January 2023 are preliminary. For

Clinical Laserthermia Systems to host Strategy Update Event on February 15

Lund, Sweden – Clinical Laserthermia Systems AB (publ) (“CLS” or “the Company”) invites investors, anlysts and media to attend a Strategy Update Event on February 15, 2023 at 13.00-15.00 CET.The Strategy Update is a hybrid event. Participants are welcome to participate either physically, at the Redeye office, Mäster Samuelsgatan 42, 10th floor, Stockholm, Sweden, or digitally.   Dan J. Mogren, CEO of CLS, and members from the management team will present the company´s strategic priorities and its commercial roll-out. The presentations will be held in English.   Following the

Alelion Energy Systems secures financing

Alelion Energy Systems secures financing by extending loans and credits totalling SEK 45 million that run until March 2024Alelion Energy Systems has extended a previously granted loan of a total of SEK 30 million until March 2024 and also extended the overdraft facility of an additional SEK 15 million previously granted. The extension has taken place with the help of owner guarantees from the company's main owners and is part of the work to secure the company's financing. Behind the financing are Swedbank and three main owners who issued ownership guarantees. In parallel, work is underway

Consultation process with Swedish unions completed

LUND (SWEDEN) – Immunovia (Nasdaq Stockholm: IMMNOV), the diagnostics company that has launched the world’s first test dedicated to the early detection of pancreatic cancer, today announced that the consultation process regarding realigning its Swedish operations, announced on 19 January 2023, has been completed.    Immunovia is realigning its Swedish operations with its strategic priorities to drive R&D productivity and focus on the US commercialization of the IMMray™ PanCan-d test. Following the early experience from the research collaboration with Proteomedix that was initiated in

Nomination Board’s proposals to Nordea’s Annual General Meeting 2023 include two new Board members

Nordea Bank AbpStock exchange release – Other information disclosed according to the rules of the Exchange8 February 2023 at 9.30 EET The Shareholders’ Nomination Board of Nordea Bank Abp announces today its proposals to Nordea’s Annual General Meeting (AGM) to be held on 23 March 2023. Risto Murto and Per Strömberg are proposed as new members of the Board of Directors. The proposal of the Shareholders’ Nomination Board for the Board of Directors to be elected by the 2023 AGM comprises ten members. The proposal includes the re-election of Stephen Hester, Petra van Hoeken, John

NYAB Oyj - Managers' Transactions

NYAB PlcMANAGERS' TRANSACTIONS08 February 2023 at 09:30NYAB Oyj - Managers' Transactions____________________________________________Person subject to the notification requirementName: Mikael RitolaPosition: Member of the Board/Deputy member Issuer: NYAB OyjLEI: 743700UX7WTIOT3QO547Notification type: INITIAL NOTIFICATIONReference number: 25205/5/4 ____________________________________________Transaction date: 2023-02-07Venue: FIRST NORTH GROWTH MARKET FINLAND (FSME)Instrument type: SHAREISIN: FI4000153515Nature of transaction: ACQUISITION  Transaction

Vestas Annual Report 2022 – A challenging year with negative profitability

Vestas Wind Systems A/S, Aarhus, 8 February 2023Company announcement no. 02/2023 Vestas Annual Report 2022 – A challenging year with negative profitability Summary: Vestas’ 2022 revenue amounted to EUR 14,486m (outlook: EUR 14.5-15.5bn), with an EBIT margin before special items of (8) percent (outlook: approx. (5) percent), and total investments[1] of EUR 758m (outlook: approx. EUR 850m). The value of the combined order backlog increased to EUR 49.5bn across Power Solutions and Service. As announced on 27 January 2023, Vestas’ outlook for 2023 is as follows: Revenue is expected

BioStock: 100 days as Sensidose's Deputy CEO

The pharmaceutical company Sensidose has developed and markets a method for individualized treatment of Parkinson's disease in the advanced phase, the so-called wearing off phase or fluctuation phase. In November 2022, Philip Slätis took over as Deputy CEO and COO to accelerate the company’s business development and continued international expansion. 100 days into his new role as Sensidose's Deputy CEO, BioStock took the opportunity to feel Slätis' pulse and hear more about the company's growth plans.Read the interview with Sensidose's Deputy CEO at biostock.se: https://www.biostock.se/

Elisa's Capital Markets Day will be held on 9 March 2023 in London

ELISA INVESTOR NEWS 8 FEBRUARY 2023 AT 9:15 AMElisa’s Capital Markets Day for institutional investors and analysts will held on Thursday 9 March 2023. The venue is London Stock Exchange, 10 Paternoster Square, London EC4M 7LS. Agenda (UK time):8:00 am Registration and breakfast 9:00 am Opening of the CMD · Group overview, CEO Veli-Matti Mattila · Consumer Customers business, EVP Vesa-Pekka Nikula · Corporate Customers business, EVP Timo Katajisto · International Digital Services, EVP Henri Korpi · Financial overview, CFO Jari Kinnunen · Q&A · Closing remarks,

There are no items matching the current filter
There are no more items matching the current filter
Back to top